Potent Activity of High Concentration Ozone Therapy Against Antibiotic-Resistant Bacteria
(1) Background: Health Care-Associated Infections (HAIs)are a significant public health problem worldwide favoring multidrug-resistant (MDR) microorganisms. The SARS-CoV-2 infection had a negative association with the increase in antimicrobial resistance, and the ESKAPE group had the most significant impact on HAIs. The study aimed to evaluate the bactericidal effect of high concentration O3 gas on some reference and ESKAPE bacteria. (2) Material and Methods: Four standard strains and four clinical or environmental MDR strains were exposed to high ozone doses at different concentrations and times. Bacterial inactivation (growth and cultivability) was investigated using colony counts and resazurin as a metabolic indicator. Scanning electron microscopy (SEM) was performed. (3) Results: The culture exposure to a high level of O3 inhibited the growth of all bacterial strains tested with a statistically significant reduction in colony count compared to the control group. The cell viability of S. aureus (MRSA) (99,6%) and P. aeruginosa (XDR) (29,2%) was reduced considerably, and SEM showed damage on bacteria after O3 treatment (4) Conclusion: High doses of ozone were able to interfere in the growth of all strains studied, evidencing that ozone-based decontamination approaches may represent the future of hospital cleaning methods..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Preprints.org - (2022) vom: 01. Feb. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rangel, Karyne [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.20944/preprints202202.0003.v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
preprintsorg035131713 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | preprintsorg035131713 | ||
| 003 | DE-627 | ||
| 005 | 20230429204409.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220202s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.20944/preprints202202.0003.v1 |2 doi | |
| 035 | |a (DE-627)preprintsorg035131713 | ||
| 035 | |a (preprintsorg)10.20944/preprints202202.0003 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rangel, Karyne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potent Activity of High Concentration Ozone Therapy Against Antibiotic-Resistant Bacteria |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a (1) Background: Health Care-Associated Infections (HAIs)are a significant public health problem worldwide favoring multidrug-resistant (MDR) microorganisms. The SARS-CoV-2 infection had a negative association with the increase in antimicrobial resistance, and the ESKAPE group had the most significant impact on HAIs. The study aimed to evaluate the bactericidal effect of high concentration O3 gas on some reference and ESKAPE bacteria. (2) Material and Methods: Four standard strains and four clinical or environmental MDR strains were exposed to high ozone doses at different concentrations and times. Bacterial inactivation (growth and cultivability) was investigated using colony counts and resazurin as a metabolic indicator. Scanning electron microscopy (SEM) was performed. (3) Results: The culture exposure to a high level of O3 inhibited the growth of all bacterial strains tested with a statistically significant reduction in colony count compared to the control group. The cell viability of S. aureus (MRSA) (99,6%) and P. aeruginosa (XDR) (29,2%) was reduced considerably, and SEM showed damage on bacteria after O3 treatment (4) Conclusion: High doses of ozone were able to interfere in the growth of all strains studied, evidencing that ozone-based decontamination approaches may represent the future of hospital cleaning methods. | ||
| 650 | 4 | |a Life Sciences | |
| 650 | 4 | |a 500 | |
| 700 | 1 | |a Cabral, Fellipe O |e verfasserin |4 aut | |
| 700 | 1 | |a Lechuga, Guilherme Curty |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, João P.R.S. |e verfasserin |4 aut | |
| 700 | 1 | |a Villas-Bôas, Maria H.S. |e verfasserin |4 aut | |
| 700 | 1 | |a Midlej, Vitor |e verfasserin |4 aut | |
| 700 | 1 | |a De-Simone, Salvatore Giovanni |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Preprints.org |g (2022) vom: 01. Feb. |
| 773 | 1 | 8 | |g year:2022 |g day:01 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.20944/preprints202202.0003.v1 |z kostenfrei |3 Volltext |
| 912 | |a preprintsorg | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 01 |c 02 | ||